City Therapeutics Inc.
Last updated October 20, 2026
Organization details
- Legal name
- City Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CTY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002143850
Board of directors
-
Andrew C. Orth · Director · President & CEOSince 2026
-
Barry E. Greene · DirectorSince 2026
- Since 2026
- Since 2026
-
Ron M. Philip · DirectorSince 2026
-
Sara Nochur · DirectorSince 2026
Chief executives
Andrew C. Orth
· President & CEO
Dates unknown
Board connections
4 of this board's directors also sit on 16 other boards.
- via John Maraganore
- via Ron M. Philip
- via John Maraganore
- via Barry E. Greene
- via Ron M. Philip
- via John Maraganore
- via Robert Nelsen
- via Barry E. Greene
- via John Maraganore
- via Robert Nelsen
- via Robert Nelsen
- via John Maraganore
- via John Maraganore
- via Robert Nelsen
- via John Maraganore
- via Robert Nelsen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $6,120,000
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 19, 2026 | ARCH Venture Partners XII, LLC 10% owner | Derivative conversion | +3,294,900 | — | — |
| Oct 19, 2026 | John Maraganore Director | Derivative conversion | +610,759 | — | — |
| Oct 19, 2026 | Robert Nelsen Director, 10% owner | Derivative conversion | +3,294,900 | — | — |
| Oct 19, 2026 | ARCH Venture Partners XII, LLC 10% owner | Derivative conversion | +5,482,309 | — | — |
| Oct 19, 2026 | Robert Nelsen Director, 10% owner | Derivative conversion | +5,482,309 | — | — |
| Oct 19, 2026 | ARCH Venture Partners XII, LLC 10% owner | Derivative conversion | +2,027,006 | — | — |
| Oct 19, 2026 | Robert Nelsen Director, 10% owner | Derivative conversion | +2,027,006 | — | — |
| Oct 19, 2026 | ARCH Venture Partners XII, LLC 10% owner | Open-market purchase | +170,000 | $18.00 | $3,060,000 |
| Oct 19, 2026 | Robert Nelsen Director, 10% owner | Open-market purchase | +170,000 | $18.00 | $3,060,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.